openPR Logo
Press release

Investigation announced for Long-Term Investors in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) over potential Wrongdoing

An investigation on behalf of current long term investors in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) shares.

An investigation on behalf of current long term investors in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) shares.

An investigation was announced for current long-term investors in shares of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) concerning potential breaches of fiduciary duties by certain directors of Rocket Pharmaceuticals, Inc..

Investors who are current long term investors in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: RCKT stocks follows a lawsuit filed against Rocket Pharmaceuticals, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: RCKT stocks, concerns whether certain Rocket Pharmaceuticals, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges that the Defendants' statements included, among other things, confidence in the drug's safety and efficacy, as well as the clinical trial's detailed protocol and Rocket's purported ability to meet the trial's endpoints as per the Company's ascribed timeline, and that the defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RPA501's safety and clinical trial protocol; notably, that Rocket knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders.

Those who purchased shares of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) over potential Wrongdoing here

News-ID: 4174417 • Views:

More Releases from Shareholders Foundation, Inc.

Fiserv, Inc. (NYSE: FI) Investor Alert: Deadline in Lawsuit on September 22, 2025
Fiserv, Inc. (NYSE: FI) Investor Alert: Deadline in Lawsuit on September 22, 202 …
A deadline is coming up on September 22, 2025 in the lawsuit filed for certain investors of Fiserv, Inc. (NYSE: FI) over alleged securities laws violations by Fiserv, Inc. Investors who purchased shares of Fiserv, Inc. (NYSE: FI) have certain options and there are strict and short deadlines running. Deadline: September 22, 2025. Fiserv, Inc. (NYSE: FI) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Lawsuit filed for Investors who lost money with shares of LifeMD, Inc. (NASDAQ: LFMD)
Lawsuit filed for Investors who lost money with shares of LifeMD, Inc. (NASDAQ: …
An investor, who purchased shares of LifeMD, Inc. (NASDAQ: LFMD), filed a lawsuit over alleged violations of Federal Securities Laws by LifeMD, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and for certain investors are short and strict deadlines running. Deadline: October 27, 2025. NASDAQ: LFMD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Alto Neuroscience, Inc. (NYSE: ANRO) Investor Alert: Deadline in Lawsuit on September 19, 2025
Alto Neuroscience, Inc. (NYSE: ANRO) Investor Alert: Deadline in Lawsuit on Sept …
A deadline is coming up on September 19, 2025 in the lawsuit filed for certain investors of Alto Neuroscience, Inc. (NYSE: ANRO) over alleged securities laws violations by Alto Neuroscience, Inc. Investors who purchased shares of Alto Neuroscience, Inc. (NYSE: ANRO) have certain options and there are strict and short deadlines running. Deadline: September 19, 2025. Alto Neuroscience, Inc. (NYSE: ANRO) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or
Neogen Corporation (NASDAQ: NEOG) Investor Alert: Deadline in Lawsuit on September 16, 2025
Neogen Corporation (NASDAQ: NEOG) Investor Alert: Deadline in Lawsuit on Septemb …
A deadline is coming up on September 16, 2025 in the lawsuit filed for certain investors of Neogen Corporation (NASDAQ: NEOG) over alleged securities laws violations by Neogen Corporation. Investors who purchased shares of Neogen Corporation (NASDAQ: NEOG) have certain options and there are strict and short deadlines running. Deadline: September 16, 2025. Neogen Corporation (NASDAQ: NEOG) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According

All 5 Releases


More Releases for Rocket

Rocket Hybrid Propulsion Market to Reach $2 Billion by 2031, Rocket Motor Segmen …
According to a new report published by Allied Market Research, titled, "Rocket Hybrid Propulsion Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type, by Orbit, by Component, by Vehicle Type, by End User : Global Opportunity Analysis and Industry Forecast, 2021-2031". The research provides a current evaluation of the global market landscape, highlighting recent trends, key drivers, and the overall market environment. The study examines the main factors
Key Influencer in the Rocket Engines Market 2025: Surge In Rocket Launches Boost …
What combination of drivers is leading to accelerated growth in the rocket engines market? The rocket engines market is projected to expand due to the rise in rocket launches in the forecasted period. In the coming ten years, a multitude of enterprises and governmental institutions globally have proposals to launch rockets and deploy numerous satellites in large constellations in low-Earth orbit. For example, as reported by the U.S. International Trade Commission,
Prominent Rocket and Missile Market Trend for 2025: Strategic Innovations In The …
What market dynamics are playing a key role in accelerating the growth of the rocket and missile market? The increase in terrorist activities and geopolitical uncertainties is anticipated to propel the expansion of the rockets and missiles market. Terrorism, characterized by employing threat or violent acts to instill fear, aims to manipulate or compel a government and its citizens to advocate specific political or societal objectives. Such conflict and extreme political
Rocket Propulsion Market
The "Rocket Propulsion Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Rocket Propulsion Market, 2024-2031 Verified Market Research's most recent report, "Rocket Propulsion Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination
Rocket Liquid Propulsion Market Growth Outlook to 2028 - ROCKET LAB USA, Safran, …
Rocket Liquid Propulsion Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Rocket Motor, Rocket Engine); Orbit (Low Earth Orbit (LEO), Medium Earth Orbit (MEO), Geostationary Earth Orbit (GEO), Beyond Geosynchronous Orbit (BGEO)); End-user (Military and Government, Commercial) and Geography A rocket may be an aircraft, a spacecraft, a missile, or some other thrust-generating vehicle. The rockets propulsion system generates thrust. Strong, liquid, and hybrid propellants are used
Model Rocket Market Evaluation with Key Companies Estes Rockets, Madcow Rocketry …
“Model Rocket Market 2019-2026” report gives distinctive insights worldwide market competition for Model Rocket. Focusing on objectives of this report is to categorize dynamics of the market and to supply latest updates like mergers and acquisitions, numerous technological developments, new entrants within the market, that create an impression on totally different segments of the Model Rocket market. Get Detail Sample: https://inforgrowth.com/sample-request/6337318/model-rocket-market Top-Manufacturers of Model Rocket market Estes Rockets, Madcow Rocketry, Custom Rocket Company,